ARTICLE | Clinical News
Soltara norastemizole regulatory update
March 19, 2001 8:00 AM UTC
SEPR submitted an NDA for its third generation nonsedating antihistamine Soltara norastemizole to treat allergic rhinitis. SEPR developed Soltara with Johnson & Johnson (JNJ, New Brunswick, N.J.), wh...